Blockchain Registration Transaction Record

Aclarion's Nociscan Gains Traction at London Clinic, Aiding Back Pain Diagnosis

Aclarion releases video on Nociscan adoption at The London Clinic. The tool uses AI & biomarkers to pinpoint chronic low back pain sources, with nearly 100 scans performed.

Chronic low back pain is a pervasive and often debilitating condition affecting hundreds of millions globally, frequently leading to significant healthcare costs, lost productivity, and reduced quality of life. Traditional diagnostic methods like MRI can show structural issues but don't always pinpoint the specific source of pain, sometimes resulting in ineffective treatments or unnecessary procedures. Nociscan's technology aims to bridge this diagnostic gap by providing biochemical evidence of disc pain. Its growing adoption at a leading clinic like The London Clinic suggests it is moving from a novel concept to a practical clinical tool. For patients, this could mean more accurate diagnoses, better-targeted treatments (potentially including more successful surgeries), and reduced trial-and-error in managing their pain. For the healthcare system, it offers the potential to improve treatment outcomes and optimize resource allocation by ensuring interventions are directed where they are most likely to be effective.